Life Sciences market research reports by DelveInsight

• Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiopoietin 2 (Ang-2) Inhibitor development. The report provides detailed coverage of the pipeline l ... Read More

• Anti-CD33 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD33 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Anti-CD37 Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-CD37 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• Anti-CD38 antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  DelveInsight’s, “Anti-CD38 antibody - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More

• Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landscape ... Read More

• Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides detailed coverage of the pipeline l ... Read More

• Autophagy modulators - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Autophagy modulators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Autophagy modulators development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More

• Endothelin Receptor Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  DelveInsight’s, “Endothelin Receptor Antagonist - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Endothelin Receptor Antagonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Receptor (GPCR) Agonist development. The report provides detailed coverage ... Read More

• Selectin Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Selectin Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Selectin Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More

• TGF-Beta-2 Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “TGF-Beta-2 Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TGF-Beta-2 Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More

• TIM-3 Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “TIM-3 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TIM-3 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More

• Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor ... Read More

• Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Ubiquitin Specific Proteases (USP) Inhibitor development. The report provides detailed co ... Read More

• Androgen receptor antagonists - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  DelveInsight’s, “Androgen receptor antagonists - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Androgen receptor antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More

• 5-Alpha Reductase Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “5-Alpha Reductase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-Alpha Reductase Inhibitor development. The report provides detailed coverage of the pipeline landscape f ... Read More

• 50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 50S Ribosomal Subunit (50S RNA) Inhibitor development. The report provides detailed coverage ... Read More

• 5-HT1A Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “5-HT1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More

• 5-HT1D Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  DelveInsight’s, “5-HT1D Agonist - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in 5-HT1D Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ass ... Read More

• 5-HT6 Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “5-HT6 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT6 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More

• 5-HT2C Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,500

  “5-HT2C Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More

• 5-HT4 Partial Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “5-HT4 Partial Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Partial Agonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More

• Adenosine A2A Receptor Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Adenosine A2A Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Agonist development. The report provides detailed coverage of the pipeline lands ... Read More

• Adrenergic Antagonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  “Adrenergic Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adrenergic Antagonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More

• Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist development. The rep ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >